http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-8602854-D0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H11-04
filingDate 1986-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_521a2a27708053069c5ccbfd57468809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd920276580654f24d9b6dc78446782b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60c52f7e83c38b911723df8dea5c8809
publicationDate 1986-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SE-8602854-D0
titleOfInvention NEW SACCHARIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
abstract New saccharides having the formula (I), wherein R'1, R'2, R'3 and R'4 are different or identical and independently represent hydrogen or an optionally substituted acyl group and W, X, Y and Z are identical or different and independently represent oxygen or an imino group with the proviso that a) at least one of the substituents R'1, R'2, R'3 and R'4 represents an acyl group and b) when Z and X are an imino group, and W and Y are oxygen alpha ) R'1 and R'2 do not simultaneously represent (R)-3-hydroxytetradecanoyl, when R'3 and R'4 are identical and represent (R)-3-hydroxytetradecanoyl, or when R'4 is (R)-3-dodecanoyloxytetradecanoyl and R'3 represent tetradecanoyloxidtetradecanoyl, beta ) R'2 is not hydrogen or (R)-3-hydroxytetradecanoyl when R'1 and R'3 are hydrogen and R'4 is (R)-3-hydroxytetradecanoyl, and gamma ) R'1 and R'3 are not the group-(CO)2.CH2.(CHOH)4.CH2OH when the other substituents are hydrogen. Other new saccharides have the formula (III), wherein R''1 and R''2 are different or identical and are independently from each other hydrogen or an optionally substituted acyl group and a) Y is O and X is NH, but alpha when R''1 is (R)-3-hydroxytetradecanoyl, R''2 is not (R)-3-hydroxytetradecanoyl or (R)-3-hexadecanoyloxytetradecanoyl, beta R''1 is not hydrogen and gamma R''1 and R''2 are not the acetyl group or the group -CO.(CH2)10.CH3, b) Y is O and X is O and c) Y is NH and X is O. The invention also relates to the process for the production and utilization thereof as pharmaceutical agents.
priorityDate 1985-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397158

Total number of triples: 21.